1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Virus Filtration Market by Product, Application, Devices, Air, Water Purification, End User - Global Forecast to 2020

The global virus filtration market is projected to reach USD 3.25 billion by 2020 from USD 1.82 billion in 2015, at a CAGR of 12.3% between 2015 and 2020. By product, the market includes kits and reagents, filtration systems, other products and services. Based on application segment includes biologicals, medical devices, water purification, and air purification. The biologicals segment is further classified into, vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissue and tissue products and stem cell products.

The end user segments included in this report are pharmaceutical & biotechnology companies, contract research organizations, academic research institutes and medical devices companies. The pharmaceutical & biotechnology companies segment is expected to hold the largest share of the virus filtration market in 2015.

The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global the virus filtration market in 2015. Asia is expected to register the fastest growth during the forecast period.

The growth of this market is mainly driven by the rise in R&D expenditure, growth of biopharmaceutical industry, and increasing government support for pharmaceutical and biotechnology industry are driving factors of the virus filtration market. In addition, increasing adoption of single-use technologies is the latest trend observed in the virus filtration market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global virus filtration market and its sub-segments. All percentage shares, splits, and breakdowns for market segments were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been considered, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub segment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all sub segments. It maps market sizes and growth rates for each sub segment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders such as
Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), and Pall Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan) and WuXi PharmaTech (Cayman) Inc. (China).


Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:
- Product Development/Innovation: Product portfolios of the top players in the virus filtration market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market
- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the virus filtration market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various virus filtration across geographies
- Market Diversification: Exhaustive information about new products, recent developments, and investments in the virus filtration market

Table Of Contents

Virus Filtration Market by Product, Application, Devices, Air, Water Purification, End User - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 MARKET SIZE ESTIMATION 21
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.3 MARKET SHARE ESTIMATION 25
2.3.1 KEY DATA FROM SECONDARY SOURCES 25
2.3.2 KEY DATA FROM PRIMARY SOURCES 26
2.4 ASSUMPTIONS FOR THE STUDY 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 32
4.1 VIRUS FILTRATION MARKET OVERVIEW 32
4.2 LIFE CYCLE ANALYSIS, BY REGION 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.1.1 BY PRODUCT 37
5.1.2 BY APPLICATION 38
5.1.3 BY END USER 38
5.2 MARKET DYNAMICS 39
5.2.1 DRIVERS 40
5.2.1.1 Increasing RandD spending 40
5.2.1.2 Growth in biopharmaceutical industry 41
5.2.1.3 Increasing government support for the pharmaceutical and biotechnology industry 41
5.2.2 RESTRAINTS 42
5.2.2.1 Stringent regulations for validation of filtration products 42
5.2.2.2 Highly consolidated market 43
5.2.3 OPPORTUNITIES 43
5.2.3.1 Asia presents high-growth opportunities 43
5.2.3.2 Increasing pharmaceutical outsourcing 44
5.2.4 TREND 45
5.2.4.1 Rising adoption of single-use technologies 45
6 VIRUS FILTRATION MARKET, BY PRODUCT 46
6.1 INTRODUCTION 47
6.2 KITS AND REAGENTS 49
6.3 FILTRATION SYSTEMS 50
6.4 SERVICES 52
6.5 OTHER PRODUCTS 53
7 VIRUS FILTRATION MARKET, BY APPLICATION 55
7.1 INTRODUCTION 56
7.2 BIOLOGICALS 58
7.2.1 VACCINES AND THERAPEUTICS 60
7.2.2 BLOOD AND BLOOD PRODUCTS 62
7.2.3 CELLULAR AND GENE THERAPY PRODUCTS 63
7.2.4 TISSUE AND TISSUE PRODUCTS 65
7.2.5 STEM CELL PRODUCTS 66
7.3 MEDICAL DEVICES 68
7.4 WATER PURIFICATION 69
7.5 AIR PURIFICATION 70
8 VIRUS FILTRATION MARKET, BY END USER 72
8.1 INTRODUCTION 73
8.2 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES 75
8.3 CONTRACT RESEARCH ORGANIZATIONS 77
8.4 ACADEMIC RESEARCH INSTITUTES 79
8.5 MEDICAL DEVICE COMPANIES 80
9 VIRUS FILTRATION MARKET, BY REGION 82
9.1 INTRODUCTION 83
9.2 NORTH AMERICA 85
9.2.1 U.S. 92
9.2.2 CANADA 96
9.3 EUROPE 101
9.4 ASIA 106
9.4.1 CHINA 112
9.4.2 JAPAN 116
9.4.3 INDIA 121
9.4.4 REST OF ASIA (ROA) 125
9.5 REST OF THE WORLD (ROW) 130
10 COMPETITIVE LANDSCAPE 135
10.1 INTRODUCTION 135
10.2 STRATEGIC OVERVIEW 135
10.3 MARKET SHARE ANALYSIS 136
10.4 COMPETITIVE SITUATION AND TRENDS 137
10.4.1 NEW PRODUCT LAUNCHES AND UPGRADES 138
10.4.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 139
10.4.3 MERGERS and ACQUISITIONS 140
10.4.4 EXPANSIONS 141
11 COMPANY PROFILES 142
(Overview, Financials, Products and Services, Strategy, and Developments)*
11.1 INTRODUCTION 142
11.2 MERCK KGAA 143
11.3 GENERAL ELECTRIC COMPANY 147
11.4 THERMO FISHER SCIENTIFIC, INC. 151
11.5 LONZA GROUP LTD. 155
11.6 PALL CORPORATION 159
11.7 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 162
11.8 SIGMA-ALDRICH CORPORATION 165
11.9 SARTORIUS AG 168
11.10 ASAHI KASEI MEDICAL CO., LTD. 171
11.11 WUXI PHARMATECH (CAYMAN) INC. 174
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
12 APPENDIX 177
12.1 INSIGHTS OF INDUSTRY EXPERTS 177
12.2 DISCUSSION GUIDE 178
12.3 OTHER DEVELOPMENTS 180
12.4 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 181
12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 183
12.6 AVAILABLE CUSTOMIZATIONS 184
12.7 RELATED REPORTS 185


LIST OF TABLES

TABLE 1 VIRUS FILTRATION MARKET SUMMARY 28
TABLE 2 INCREASING RandD SPENDING: THE PRIMARY GROWTH DRIVER FOR THE VIRUS FILTRATION MARKET 42
TABLE 3 STRINGENT REGULATORY POLICIES FOR VALIDATION OF FILTRATION PRODUCTS TO RESTRICT MARKET GROWTH 43
TABLE 4 ASIA PRESENTS HIGH-GROWTH OPPORTUNITIES IN THE VIRUS FILTRATION MARKET 44
TABLE 5 SINGLE-USE TECHNOLOGIES IS A MAJOR TREND OBSERVED IN THE VIRUS FILTRATION MARKET 45
TABLE 6 VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 48
TABLE 7 VIRUS FILTRATION KITS AND REAGENTS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 50
TABLE 8 VIRUS FILTRATION SYSTEMS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 51
TABLE 9 VIRUS FILTRATION SERVICES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 53
TABLE 10 OTHER VIRUS FILTRATION PRODUCTS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 54
TABLE 11 VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 57
TABLE 12 VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,
2013-2020 (USD MILLION) 59
TABLE 13 VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY REGION,
2013-2020 (USD MILLION) 60
TABLE 14 VIRUS FILTRATION MARKET SIZE FOR VACCINES AND THERAPEUTICS, BY REGION, 2013-2020 (USD MILLION) 61
TABLE 15 VIRUS FILTRATION MARKET SIZE FOR BLOOD AND BLOOD PRODUCTS, BY REGION, 2013-2020 (USD MILLION) 63
TABLE 16 VIRUS FILTRATION MARKET SIZE FOR CELLULAR AND GENE THERAPY PRODUCTS, BY REGION, 2013-2020 (USD MILLION) 64
TABLE 17 VIRUS FILTRATION MARKET SIZE FOR TISSUE AND TISSUE PRODUCTS, BY REGION, 2013-2020 (USD MILLION) 66
TABLE 18 VIRUS FILTRATION MARKET SIZE FOR STEM CELL PRODUCTS, BY REGION,
2013-2020 (USD MILLION) 67
TABLE 19 VIRUS FILTRATION MARKET SIZE FOR MEDICAL DEVICES, BY REGION,
2013-2020 (USD MILLION) 68
TABLE 20 VIRUS FILTRATION MARKET SIZE FOR WATER PURIFICATION APPLICATIONS,
BY REGION, 2013-2020 (USD MILLION) 70
TABLE 21 VIRUS FILTRATION MARKET SIZE FOR AIR PURIFICATION APPLICATIONS,
BY REGION, 2013-2020 (USD MILLION) 71
TABLE 22 VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 74
TABLE 23 VIRUS FILTRATION MARKET SIZE FOR PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION) 76
TABLE 24 VIRUS FILTRATION MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS,
BY REGION, 2013-2020 (USD MILLION) 78
TABLE 25 VIRUS FILTRATION MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2013-2020 (USD MILLION) 79
TABLE 26 VIRUS FILTRATION MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY REGION, 2013-2020 (USD MILLION) 81
TABLE 27 VIRUS FILTRATION MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 84
TABLE 28 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 87
TABLE 29 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 88
TABLE 30 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 89
TABLE 31 NORTH AMERICA: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 90
TABLE 32 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 91
TABLE 33 U.S.: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 93
TABLE 34 U.S.: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 94
TABLE 35 U.S.: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 95
TABLE 36 U.S.: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 96
TABLE 37 CANADA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 97
TABLE 38 CANADA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 98
TABLE 39 CANADA: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 99
TABLE 40 CANADA: VIRUS FILTRATION MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 100
TABLE 41 EUROPE: VIRUS FILTRATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 102
TABLE 42 EUROPE: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 103
TABLE 43 EUROPE: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 104
TABLE 44 EUROPE: VIRUS FILTRATION MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 105
TABLE 45 ASIA: VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 107
TABLE 46 ASIA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 108
TABLE 47 ASIA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 109
TABLE 48 ASIA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,
2013-2020 (USD MILLION) 110
TABLE 49 ASIA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 111
TABLE 50 CHINA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 113
TABLE 51 CHINA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 114
TABLE 52 CHINA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,
2013-2020 (USD MILLION) 115
TABLE 53 CHINA: VIRUS FILTRATION MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 116
TABLE 54 JAPAN: VIRUS FILTRATION MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 117
TABLE 55 JAPAN: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 118
TABLE 56 JAPAN: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,
2013-2020 (USD MILLION) 119
TABLE 57 JAPAN: VIRUS FILTRATION MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 120
TABLE 58 INDIA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 122
TABLE 59 INDIA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 123
TABLE 60 INDIA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,
2013-2020 (USD MILLION) 124
TABLE 61 INDIA: VIRUS FILTRATION MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 125
TABLE 62 ROA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 126
TABLE 63 ROA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 127
TABLE 64 ROA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,
2013-2020 (USD MILLION) 128
TABLE 65 ROA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 129
TABLE 66 ROW: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 131
TABLE 67 ROW: VIRUS FILTRATION MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 132
TABLE 68 ROW: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE,
2013-2020 (USD MILLION) 133
TABLE 69 ROW: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 134
TABLE 70 MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND MARCH 2016 137
TABLE 71 NEW PRODUCT LAUNCHES AND UPGRADES, 2013-2016 138
TABLE 72 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2016 139
TABLE 73 MERGERS and ACQUISITIONS, 2013-2016 140
TABLE 74 EXPANSIONS, 2013-2016 141


LIST OF FIGURES

FIGURE 1 GLOBAL VIRUS FILTRATION MARKET 18
FIGURE 2 RESEARCH DESIGN 20
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 22
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 22
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 23
FIGURE 6 DATA TRIANGULATION METHODOLOGY 24
FIGURE 7 VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION) 29
FIGURE 8 VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION) 29
FIGURE 9 BIOLOGICALS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION) 30
FIGURE 10 VIRUS FILTRATION MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION) 31
FIGURE 11 VIRUS FILTRATION MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION) 31
FIGURE 12 GLOBAL VIRUS FILTRATION MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD 32
FIGURE 13 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE THE VIRUS FILTRATION MARKET IN 2015 33
FIGURE 14 ASIA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 34
FIGURE 15 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES 35
FIGURE 16 VIRUS FILTRATION MARKET SEGMENTATION: BY PRODUCT 37
FIGURE 17 VIRUS FILTRATION MARKET SEGMENTATION: BY APPLICATION 38
FIGURE 18 VIRUS FILTRATION MARKET SEGMENTATION: BY END USER 38
FIGURE 19 INCREASING RandD SPENDING WILL DRIVE THE VIRUS FILTRATION MARKET DURING THE FORECAST PERIOD 39
FIGURE 20 GLOBAL PHARMACEUTICAL RandD SPENDING (2001-2011) 40
FIGURE 21 VIRUS FILTRATION MARKET SEGMENTATION, BY PRODUCT 47
FIGURE 22 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN 2015 48
FIGURE 23 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION KITS AND REAGENTS MARKET IN 2015 49
FIGURE 24 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION SYSTEMS MARKET IN 2015 51
FIGURE 25 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF VIRUS FILTRATION SERVICES MARKET IN 2015 52
FIGURE 26 NORTH AMERICA TO DOMINATE THE OTHER VIRUS FILTRATION PRODUCTS MARKET IN 2015 53
FIGURE 27 VIRUS FILTRATION MARKET SEGMENTATION, BY APPLICATION 56
FIGURE 28 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATIONS MARKET
IN 2015 57
FIGURE 29 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015 58
FIGURE 30 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015 59
FIGURE 31 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR VACCINES AND THERAPEUTICS IN 2015 61
FIGURE 32 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR BLOOD AND BLOOD PRODUCTS IN 2015 62
FIGURE 33 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR CELLULAR AND GENE THERAPY PRODUCTS IN 2015 64
FIGURE 34 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR TISSUE AND TISSUE PRODUCTS IN 2015 65
FIGURE 35 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR STEM CELL PRODUCTS IN 2015 67
FIGURE 36 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR MEDICAL DEVICES IN 2015 68
FIGURE 37 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION MARKET FOR WATER PURIFICATION APPLICATIONS IN 2015 69
FIGURE 38 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR AIR PURIFICATION APPLICATIONS IN 2015 70
FIGURE 39 VIRUS FILTRATION MARKET SEGMENTATION, BY END USER 73
FIGURE 40 VIRUS FILTRATION MARKET SIZE, BY END USER, 2015 (USD MILLION) 74
FIGURE 41 PATENTS FILED: GLOBAL DISTRIBUTION IN 2012 75
FIGURE 42 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES IN 2015 76
FIGURE 43 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS BETWEEN 2015 AND 2020 78
FIGURE 44 ASIA TO WITNESS HIGHEST GROWTH IN THE VIRUS FILTRATION MARKET FOR ACADEMIC RESEARCH INSTITUTES 79
FIGURE 45 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR MEDICAL DEVICE COMPANIES BETWEEN 2015 AND 2020 80
FIGURE 46 VIRUS FILTRATION MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2015-2020 83
FIGURE 47 VIRUS FILTRATION MARKET IN ASIA TO GROW AT THE HIGHEST RATE (2015 TO 2020) 84
FIGURE 48 NORTH AMERICA: VIRUS FILTRATION MARKET SNAPSHOT 86
FIGURE 49 U.S. TO DOMINATE THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015 87
FIGURE 50 KITS and REAGENTS ESTIMATED TO FORM THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015 88
FIGURE 51 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015 89
FIGURE 52 VACCINES and THERAPEUTICS ESTIMATED TO FORM THE LARGEST SEGMENT IN THE NORTH AMERICAN BIOLOGICALS MARKET IN 2015 90
FIGURE 53 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN NORTH AMERICA 91
FIGURE 54 KITS and REAGENTS ESTIMATED TO FORM THE LARGEST PRODUCT SEGMENT IN THE U.S. VIRUS FILTRATION MARKET IN 2015 92
FIGURE 55 BIOLOGICALS APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. VIRUS FILTRATION MARKET IN 2015 93
FIGURE 56 VACCINES and THERAPEUTICS ESTIMATED TO FORM THE LARGEST SEGMENT IN THE U.S. VIRUS FILTRATION BIOLOGICALS MARKET IN 2015 94
FIGURE 57 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN THE U.S. 95
FIGURE 58 KITS and REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN CANADA IN 2015 97
FIGURE 59 BIOLOGICALS TO ACCOUNT FOR THE LARGEST OF THE VIRUS FILTRATION APPLICATIONS MARKET IN CANADA IN 2015 98
FIGURE 60 KITS and REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT OF VIRUS FILTRATION BIOLOGICALS MARKET IN CANADA 99
FIGURE 61 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN CANADA 100
FIGURE 62 KITS and REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE EUROPEAN VIRUS FILTRATION MARKET IN 2015 101
FIGURE 63 BIOLOGICALS TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION APPLICATIONS MARKET IN EUROPE IN 2015 102
FIGURE 64 VACCINES AND THERAPEUTICS TO FORM THE LARGEST SEGMENT IN THE VIRUS FILTRATION BIOLOGICALS MARKET IN EUROPE 103
FIGURE 65 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN EUROPE 104
FIGURE 66 ASIAN VIRUS FILTRATION MARKET SNAPSHOT 106
FIGURE 67 CHINA ESTIMATED TO DOMINATE THE ASIAN VIRUS FILTRATION MARKET IN 2015 107
FIGURE 68 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE ASIAN MARKET IN 2015 108
FIGURE 69 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION APPLICATION MARKET IN ASIA IN 2015 109
FIGURE 70 VACCINES AND THERAPEUTICS TO DOMINATE THE ASIAN VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015 110
FIGURE 71 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN ASIA 111
FIGURE 72 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE VIRUS FILTRATION MARKET IN CHINA IN 2015 112
FIGURE 73 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATIONS MARKET IN CHINA IN 2015 113
FIGURE 74 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN CHINA IN 2015 114
FIGURE 75 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN CHINA 115
FIGURE 76 KITS AND REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN JAPAN IN 2015 117
FIGURE 77 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN JAPAN IN 2015 118
FIGURE 78 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN JAPAN IN 2015 119
FIGURE 79 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN JAPAN 120
FIGURE 80 KITS AND REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN INDIA IN 2015 121
FIGURE 81 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN INDIA IN 2015 122
FIGURE 82 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN INDIA IN 2015 123
FIGURE 83 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN INDIA 124
FIGURE 84 KITS AND REAGENTS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE VIRUS FILTRATION MARKET IN ROA IN 2015 126
FIGURE 85 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN ROA IN 2015 127
FIGURE 86 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN ROA IN 2015 128
FIGURE 87 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN ROA 129
FIGURE 88 KITS AND REAGENTS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ROW VIRUS FILTRATION MARKET IN 2015 130
FIGURE 89 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW VIRUS FILTRATION APPLICATION MARKET IN 2015 131
FIGURE 90 VACCINES AND THERAPEUTICS ESTIMATED TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN ROW IN 2015 132
FIGURE 91 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW VIRUS FILTRATION END-USER MARKET 133
FIGURE 92 NEW PRODUCT LAUNCHES AND UPGRADES WAS THE KEY STRATEGY ADOPTED
BY PLAYERS IN THE VIRUS FILTRATION MARKET 135
FIGURE 93 VIRUS FILTRATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 136
FIGURE 94 FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS 142
FIGURE 95 COMPANY SNAPSHOT: MERCK and CO., INC. 143
FIGURE 96 COMPANY SNAPSHOT: GENERAL ELECTRIC COMPANY 147
FIGURE 97 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC. 151
FIGURE 98 COMPANY SNAPSHOT: LONZA GROUP LTD. 155
FIGURE 99 COMPANY SNAPSHOT: PALL CORPORATION 159
FIGURE 100 COMPANY SNAPSHOT: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 162
FIGURE 101 COMPANY SNAPSHOT: SIGMA-ALDRICH CORPORATION 165
FIGURE 102 COMPANY SNAPSHOT: SARTORIUS AG 168
FIGURE 103 COMPANY SNAPSHOT: ASAHI KASEI MEDICAL CO., LTD. 171
FIGURE 104 COMPANY SNAPSHOT: WUXI PHARMATECH (CAYMAN) INC. 174

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.